Avience Biomedicals IPO Allotment Status: Steps to Verify Status
The allotment status for the ₹30.24 crore Avience Biomedicals IPO is expected to be announced today, June 23, 2026. Investors will be able to verify their IPO allotment through the official channels, including the websites of the NSE and the IPO registrar, Skyline Financial Services Limited.
Following the completion of the allotment process, the shares are expected to be listed on the NSE Emerge platform on June 25, 2026.
Procedure to Check Avience Biomedicals IPO Allotment Status Online On NSE
- Visit the NSE’s IPO allotment status page here.
- Select “ Equity & SME IPO Bid Details”.
- In Select Symbol, select “AVIENCE”.
- Enter your PAN Number and Application Number.
- Click “Submit”.
Procedure to Check Avience Biomedicals IPO Allotment Status on Skyline Financial Services Private Limited (Registrar to the issue)
- Visit the Skyline Financial Services IPO allotment status page here.
- In Company Name, select “AVIENCE BIOMEDICALS LIMITED”.
- Enter any of the following details.
- DPID/Client ID/ Folio Number
- CAF Number
- PAN Number
- Click “Search”.
Avience Biomedicals IPO - Issue Details
- Issue Type: Book Building IPO (Fresh Issue Only)
- Total Issue Size: ₹30.24 crore
- Fresh Issue: ₹30.24 crore
- Face Value: ₹10 per equity share
- Price Band: ₹196 to ₹208 per share
- Lot Size: 600 shares
- Listing: NSE SME
- Book Building Lead Managers: Fintellectual Corporate Advisors Private Limited
- Registrar: Skyline Financial Services Private Limited
Avience Biomedicals IPO Overall Subscription Status
[June 22, 2026, 7:00 PM]
|
Category |
Subscription (times) |
|
Qualified Institutional Buyers (QIBs) |
196.77x |
|
Non-Institutional Investors (NIIs) |
597.23x |
|
Retail Individual Investors (RIIs) |
401.36x |
|
Total |
385.32x |
Utilisation of Avience Biomedicals IPO Proceeds
- Part finances the capital expenditure towards setting up a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
- Funding the working capital requirements of the Company.
- General corporate purposes
Avience Biomedicals Limited Overview
Incorporated in 2019, Avience Biomedicals Limited is engaged in manufacturing in vitro diagnostic (IVD) products, diagnostic kits, and medical devices.
Based in Noida, Uttar Pradesh, the company offers products such as rapid test kits, serology products, biochemistry analysers, and reagents, serving hospitals, laboratories, research centres, and healthcare institutions across India and overseas.
In addition to manufacturing, it also trades and distributes medical equipment. Avience Biomedicals focuses on providing affordable, high-quality diagnostic solutions while expanding its product portfolio and market presence.
Financially, total income stood at ₹41.94 crore for the ten months ended January 2026, compared to ₹45.97 crore in FY25 and ₹24.37 crore in FY24. Profit after tax (PAT) stood at ₹5.74 crore during the period, while EBITDA was ₹10.34 crore, compared with ₹7.23 crore and ₹11.41 crore, respectively, in FY25.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.